NCT00368316View on ClinicalTrials.gov

Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel

PHASE3CompletedINTERVENTIONAL
Enrollment

2,799

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

February 28, 2009

Conditions
Shigellosis
Interventions
BIOLOGICAL

Shigella conjugate vaccines

Shigella sonnei-rEPA and Shigella flexneri2a rEPA vaccines

Trial Locations (2)

Unknown

Schneider Childrens Hospital, Petah Tikva

Chaim Sheba Medical Center, Tel Aviv

All Listed Sponsors
collaborator

The Chaim Sheba Medical Center

OTHER

collaborator

Schneider Children's Medical Center, Israel

OTHER

lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00368316 - Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel | Biotech Hunter | Biotech Hunter